Engineering and design of blood substitutes

Current Opinion in Structural Biology

Volumn 6, Issue 4, 1996, Pages 534-540

  Sanders, Kevin E ^a   Ackers, Gary ^b   Sligar, Stephen ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; HEMOGLOBIN;

AUTOOXIDATION; BLOOD VESSEL REACTIVITY; CHEMICAL MODIFICATION; DRUG TOXICITY; GENETIC ENGINEERING; PRIORITY JOURNAL; REVIEW;

EID: 0030220256     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-440X(96)80120-5     Document Type: Article

References (60)

1. Spence RK. Perfluorocarbons in the twenty-first century - clinical applications as transfusion alternatives. Art Cells Blood Subs Immob Biotech. 23:1995;367-380.
2. Rudolph AS. Encapsulated hemoglobin - current issues and future goals. Art Cells Blood Subs Immob Biotech. 22:1994;347-360.
3. Blantz RC, Evan AP, Gabbai FB. Red cell substitutes in the kidney. Winslow RM, Vandegriff KD, Intaglietta M. Blood Substitutes: Physiological Basis of Efficacy. 1995;132-142 Birkhaüser, Boston.
4. Walder RY, Andracki ME, Walder JA. Preparation of intramolecularly cross-linked hemoglobins. Everse J, Vandegriff KD, Winslow RM. Methods in Enzymology. 1994;274-280 Academic Press, San Diego.
5. Gould SA, Sehgal LR, Sehgal HL, Moss GS. The development of hemoglobin solutions as red cell substitutes: hemoglobin solutions. Transfusion Sci. 16:1995;5-17.
6. Hernan RA, Hui HL, Andracki ME, Noble RW, Sligar SG, Walder JA, Walder RY. Human hemoglobin expression in Escherichia coli: importance of optimal codon usage. Biochemistry. 31:1992;8619-8628.
7. Hoffman SJ, Looker DL, Roerich JM, Cozart PE, Durfee SL, Tedesco JL, Stetler GL. Expression of fully functional tetrameric human hemoglobin in Escherichia coli. Proc Natl Acad Sci USA. 87:1990;8521-8525.
8. Looker D, Abbott-Brown D, Cozart P, Durfee S, Hoffman S, Mathews A, Miller-Roehrich J, Shoemaker S, Trimble S, Fermi G, et al. A human recombinant haemoglobin designed for use as a blood substitute. Nature. 356:1992;258-260.
9. Doyle ML, Lew G, Young AD, Kwiatkowski L, Wierzba A, Noble RA, Ackers GK. Functional properties of human hemoglobin synthesized from recombinant β-globin. Biochemistry. 31:1992;8629-8639.
10. Kavanaugh JS, Rogers PH, Arnone A. High resolution X-ray study of deoxy recombinant human hemoglobins synthesized from β-globins having mutated amino termini. Biochemistry. 31:1992;8640-8647.
11. Shen T-J, Ho NT, Simplaceanu V, Zou M, Green BN, Tam MF, Ho C. Production of unmodified human adult hemoglobin in Escherichia coli. Proc Natl Acad Sci USA. 90:1993;8108-8112.
12. Hernan RA, Sligar SG. Tetrameric hemoglobin expressed in Escherichia coli: evidence of heterogeneous subunit assembly. J Biol Chem. 270:1995;26257-26264.
13. Apostol I, Aitken J, Levine J, Lippincott J, Davidson JS, Abbottbrown D. Recombinant protein sequences can trigger methylation of N-terminal amino acids in Escherichia coli. Protein Sci. 4:1995;2616-2618.
14. Wagenbach M, O'Rourke K, Vitez L, Wieczorek A, Hoffman S, Durfee S, Tedesco J, Stetler G. Synthesis of wild type and mutant hemoglobins in Saccharomyces cerevisiae. Bio-Technology. 9:1991;57-61.
15. Adachi K, Konitzer P, Lai CH, Kim J, Surrey S. Oxygen binding and other physical properties of human hemoglobin made in yeast. Protein Eng. 5:1992;807-810.
16. Hoffman OM, Mould RM, Brittain T. The incorporation of sulphaem into recombinant adult human haemoglobin produced in a yeast expression system. Protein Eng. 7:1994;281-283.
17. Coghlan D, Jones G, Denton KA, Wilson MT, Chan B, Harris R, Woodrow JR, Ogden JE. Structural and functional characterization of recombinant human hemoglobin A expressed in Saccharomyces cerevisiae. Eur J Biochem. 207:1992;931-936.
18. Swanson ME, Martin MJ, O'Donnell JK, Hoover K, Lago W, Huntress V, Parsons CT, Pinkert CA, Pilder S, Logan JS. Production of functional human hemoglobin in transgenic swine. Biotechnology. 10:1992;557-559.
19. Behringer RR, Ryan TM, Reilly MP, Asakura T, Palmiter RD, Brinster RL, Townes TM. Synthesis of functional human hemoglobin in transgenic mice. Science. 245:1990;971-973.
20. Rao MJ, Schneider K, Chait BT, Chao TL, Keller H, Anderson S, Manjula BN, Kumar R, Acharya AS. Recombinant hemoglobin A produced in transgenic swine: structural equivalence with human hemoglobin A. Art Cells Blood Subs Immob Biotech. 22:1994;695-700.
21. Katz DS, White SP, Huang W, Kumar R, Christianson DW. Structure determination of aquomet porcine hemoglobin at 2.8 angstrom resolution. J Mol Biol. 244:1994;541-553.
22. 2 interface are sufficient to create a bicarbonate binding pocket that can serve as a novel new allosteric regulator of human hemoglobin.
23. of special interest Fronticelli C, Sanna MT, Perez-Alvarado GC, Karavitis M, Lu A-L, Brinigar WS. Allosteric modulation by tertiary structure in mammalian hemoglobins. J Mol Biol. 270:1995;30588-30592 The intrinsically low, choride-dependent oxygen affinity of bovine hemoglobin is engineered into human hemoglobin by the addition of mutations an the N-terminal portion of the β-subunits. Interestingly, the new allosteric behavior is confined entirely to interaction within the β-subunits.
24. Hess JR, MacDonald VW, Brinkley WW. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol. 74:1993;1769-1778.
25. Shultz SC, Grady B, Cole F: A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. 1993, 122:301-308.
26. Vo PA, Reid JJ, Rand MJ. Attenuation of vasoconstriction by endogenous nitric oxide in rat caudal artery. Br J Pharmacol. 107:1992;1171-1178.
27. Sharma AC, Gulati A. Yohimbine modulates diaspirin crosslinked hemoglobin-induced systemic hemodynamics and regional circulatory effects. Crit Care Med. 23:1995;874-884.
28. Marcus AJ, Broekman MJ. Cell-free hemoglobin as an oxygen carrier removes nitric oxide, resulting in defective thromboregulation. Circulation. 93:1996;208-209.
29. Olsen SB, Tang DB, Jackson MR, Gomez ER, Ayala B, Alving BM. Enhancement of platelet deposition by cross-linked hemoglobin in a rat carotid endarterectomy model. Circulation. 93:1996;327-332.
30. Keipert PE, Gomez CL, Gonzales A, MacDonald VW, Hess JR, Winslow RM. Diaspirin cross-linked hemoglobin: tissue distribution and long-term excretion after exchange transfusion. J Lab Clin Med. 123:1994;701-711.
31. Lee R, Neya K, Svizzero TA, Vlahakes GJ. Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. J Appl Physiol. 79:1995;236-242.
32. Feder BJ. Race for artificial blood heats up. The New York Times. February 14, 1994;D1.
33. Gould SA, Sehgal LR. Clinical experience with human polymerized hemoglobin. Transfusion. 33:1993;60.
34. Johnson PC, Richmond K, Shonat RD, Toth A, Pal M, Tischler ME, Lynch RM. Oxygen delivery regulation: implications for blood substitutes. Winslow RM, Vandegriff KD, Intaglietta M. Blood Substitutes: Physiological Basis of Efficacy. 1995;175-186 Birkhaüser, Boston.
35. Vandegriff KD, Winslow RM. A theoretical analysis of oxygen transport: a new strategy for the design of hemoglobin-based red cell substitutes. Winslow RM, Vandegriff KD, Intaglietta M. Blood Substitutes: Physiological Basis of Efficacy. 1995;143-154 Birkhaüser, Boston.
36. Tsai AG, Kerger H, Intaglietta M. Microcirculatory consequences of blood substitution with aa-hemoglobin. Winslow RM, Vandegriff KD, Intaglietta M. Blood Substitutes: Physiological Basis of Efficacy. 1995;155-174 Birkhaüser, Boston.
37. of outstanding interest Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature. 380:1996;221-226 The authors describe the identification of a blood pressure regulatory role of hemoglobin. Cysteines in the central cavity of the tetramer bind to NO in the lungs and releases it into the vascular space, to counter the natural NO-scavenging effect of hemoglobin. In the future, this mechaninsm may be exploited to eliminate the vasoconstrictive effect of cell-free hemoglobin.
38. Alayash AI, Cashon R. Hemoglobin and free radicals: implications for the development of a safe blood substitute. Mol Medicine Today. 1:1995;122-127.
39. Vandegriff KD. Stability and toxicity of hemoglobin solutions. Winslow RM, Vandegriff KD, Intaglietta M. Blood Substitutes: Physiological Basis of Efficacy. 1995;105-131 Birkhaüser, Boston.
40. Faivre B, Menu P, Labrude P, Grandgeorge M, Vigneron C. Methemoglobin formation after administration of hemoglobin conjugated to carboxylate dextran in guinea pigs. Attempts to prevent the oxidation of hemoglobin. Art Cells Blood Subs Immob Biotech. 22:1994;1073-1199.
41. Motterlini R, Foresti R, Vandegriff K, Winslow R. The autoxidation of aa cross-linked hemoglobin: a possible role in the oxidative stress to endothelium. Art Cells Blood Subs Immob Biotech. 23:1995;291-301.
42. Miller YI, Felikman Y, Shaklai N. Hemoglobin induced apolipoprotein B crosslinking in low-density lipoprotein peroxidation. Arch Biochem Biophys. 326:1996;252-260.
43. Biro GP, Ou C, Ryan-Macfarlane C, Anderson PJ. Oxyradical generation after resuscitation of hemorrhagic shock with blood or stromafree hemoglobin solution. Art Cells Blood Subs Immob Biotech. 23:1995;631-645.
44. Faivre B, Labaeye V, Menu P, Labrude P, Vigneron C. Assessment of dextran 10-benzene-tetracarboxylate-hemoglobin, an oxygen carrier, using guinea pig isolated bowel model. Art Cells Blood Subs Immob Biotech. 23:1995;495-504.
45. Vandegriff KD, Le Telier YC. A comparison of heme exchange: site-specifically cross-linked versus polymerized human hemoglobins. Art Cells Blood Subs Immob Biotech. 22:1994;443-455.
46. Alayash AI. Effects of intra- and intermolecular crosslinking on the free radical reactions of bovine hemoglobins. Free Rad Biol Med. 18:1995;295-301.
47. Rogers MS, Ryan BB, Cashon RE, Alayash AI. Effects of polymerization on the oxygen carrying and redox properties of diaspirin cross-linked hemoglobin. Biochim Biophys Acta. 38:1995;135-142.
48. Hargrove MS, Wilkinson AJ, Olson JS. Structural factors governing hemin dissociation from myoglobin. Biochemistry. 1996;. in press.
49. Hargrove MS, Barrick D, Olson JS. The association rate constant for heme binding to globin is independent of protein structure. Biochemistry. 1996;. in press.
50. Balla J, Jacob HS, Balla G, Nath K, Eaton JW, Vercellotti GM. Endothelial-cell heme uptake from proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA. 90:1993;9285-9289.
51. of special interest Marden MC, Griffon N, Poyart C. Oxygen delivery and autoxidation of hemoglobin. Transfus Clin Biol. 2:1995;473-480 Theoretical calculations demonstrate the effects of intermediately oxidized tetramers on the oxygen affinity and cooperativity of hemoglobin. The calculations have implications for the design of blood substitutes that will maintain oxygen-carrying capacity throughout the inevitable process of being oxidized within the blood stream.
52. Cashon RE, Alayash AI. Reaction of human hemoglobin HbAo and two cross-linked derivatives with hydrogen peroxide - differential behavior of the ferryl intermediate. Arch Biochem Biophys. 316:1995;461-469.
53. Alayash AI, Fratantoni JC, Bonaventura C, Bonaventura J, Bucci E. Consequences of chemical modifications on the free radical reactions of human hemoglobin. Arch Biochem Biophys. 298:1992;114-120.
54. Osawa Y, Darbyshire JF, Meyer CA, Alayashi AI. Differential susceptibilities of the prosthetic heme of hemoglobin-based red cell substitutes - implications in the design of safer agents. Biochem Pharmacol. 46:1993;2299-2305.
55. Fronticelli C, Brinigar WS, Olson JS, Bucci E, Gryczynski Z, O'Donnell JK, Kowalczyk J. Recombinant human hemoglobin: modification of the polarity of the β-heme pocket by a valine67(E11)→threonine mutation. Biochemistry. 32:1993;1235-1242.
56. Baudin V, Dumoulin A, Poyart C, Pagnier J. Doubly mutated human hemoglobin with low oxygen affinity. Transfus Clin Biol. 2:1995;463-467.
57. Travaglini AC, Cutruzzolà F, Brancaccio A, Vallone B, Brunori M. Engineering ascaris hemoglobin oxygen affinity in sperm whale myoglobin: role of tyrosine B10. FEBS Lett. 352:1994;63-66.
58. Yang T, Olsen KW. Enzymatic protection from autoxidation for crosslinked hemoglobins. Art Cells Blood Subs Immob Biotech. 22:1994;709-717.
59. of outstanding interest Quebec EA, Chang TMS. Superoxide dismutase and catalase cross-linked to polyhemoglobin reduces methemoglobin formation in vitro. Art Cells Blood Subs Immob Biotech. 23:1995;693-705 Glutaraldehyde polymerization results in significant levels of oxidized hemoglobin; however, the addition of catalase and superoxide dismutase to the polymerization reaction reduces the oxidation of hemoglobin. In addition, the oxidation rate of the resulting polymers is less than the polymers not cross-linked to catalase and superoxide dismutase. This chemical modification described is the first to address the problems associated with increased autoxidation rates in vivo.
60. Zhao B-L, Shen J-G, Li M, Li M-f, Wan Q, Xin W-J. Scavenging effect of Chinonin on NO and oxygen free radicals and its protective effect on the myocardium from the injury of ischemia-reperfusion. Biochim Biophys Acta. 1315:1996;131-137.